Skip to main content
Panacea Life Sciences Holdings, Inc. (PLSH)
OTCMKTS: PLSH · Delayed Price · USD
0.148
0.00 (0.00%)
May 30, 2024, 10:50 AM EDT - Market closed

PLSH Revenue

Panacea Life Sciences Holdings had revenue of $2.76M in the twelve months ending March 31, 2024, with 50.38% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.06M with 55.94% year-over-year growth. In the year 2023, Panacea Life Sciences Holdings had annual revenue of $2.38M with 46.59% growth.

Revenue (ttm)
$2.76M
Revenue Growth
+50.38%
P/S Ratio
0.95
Revenue / Employee
$145,470
Employees
19
Market Cap
2.62M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.38M757.98K46.59%
Dec 31, 20221.63M-432.65K-21.01%
Dec 31, 20212.06M-6.96M-77.16%
Dec 31, 20209.02M8.67M2,508.69%
Dec 31, 2019345.68K--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 2015213.00--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 379.49B
Johnson & Johnson 81.80B
Merck & Co. 61.40B
AbbVie 54.40B
Novartis AG 49.92B
AstraZeneca 47.61B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Revenue Rankings

PLSH News

More News